missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ RIPGBM

Description
RIPGBM is a RIPK2 modulator, pro-drug of cRIPGM. cRIPGM binds RIPK2 (apparent Kd = 2.3 μM). Selectively induces apoptosis in glioblastoma multiforme cancer stem cell lines (EC50 is <500 nM). Five-fold selective for CSCs compared with control cell types. Reduces the formation of a prosurvival RIPK2/ TAK1 complex and increases the formation of a proapoptotic RIPK2/caspase 1 complex. Inhibits tumor formation and growth in vivo. Orally bioavailable and brain penetrant.
Specifications
Specifications
| Nombre del producto químico o material | N-[1,4-Dihydro-1,4-dioxo-3-[(phenylmethyl)amino]-2-naphthalenyl]-N-[(4-fluorophenyl)methyl]acetamide |
| CAS | 355406-76-7 |
| Cantidad | 50 mg |
| Objetivo | RIP Kinase Inhibitors |
| Fórmula molecular | C26H21FN2O3 |
| Formula Weight (peso de la fórmula) | 7272 |
| Pureza | 98% |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?